Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome

• Hauptverfasser: Midori Sunada (Verfasst von), Seiko Sugiyama (Verfasst von), Yukiko Nakahara (Verfasst von), Mariko Yamane (Verfasst von), Rehito Mashiko (Verfasst von), Takenobu Yamamoto (Verfasst von), Yumi Aoyama (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2023-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Many reports have described the development of bullous pemphigoid (BP) following COVID‐19 vaccination. In dipeptidyl peptidase‐4 inhibitor‐associated BP (DPP‐4i‐BP), cessation of DPP‐4i appears to have a paradoxical effect on the clinical course of the BP. Interestingly, similar...